Ingredient or product comparison
SNAP-8 vs Acetyl Hexapeptide-8 (Argireline)
The naming overlap causes frequent confusion: acetyl octapeptide-3 (SNAP-8) is an eight-residue peptide, while acetyl hexapeptide-8 (Argireline, also developed by Lipotec) is a six-residue truncation of the same SNAP-25 fragment. Both inhibit SNARE complex for
This source-based comparison does not add ratings or recommend a winner.
- The naming overlap causes frequent confusion: acetyl octapeptide-3 (SNAP-8) is an eight-residue peptide, while acetyl hexapeptide-8 (Argireline, also developed by Lipotec) is a six-residue truncation of the same SNAP-25 fragment. Both inhibit SNARE complex formation, but SNAP-8 includes two additional amino acids that extend the binding interface and increase the inhibitory potency by approximately 30% compared to Argireline. Clinical trials published in the International Journal of Cosmetic Science found that 10% SNAP-8 formulations reduced wrinkle depth by 63% after 28 days of twice-daily application, compared to 27% for 10% Argireline under identical conditions.
- Argireline (acetyl hexapeptide-8) works through competitive inhibition at the SNARE docking site, but the shorter sequence length reduces binding affinity and duration of effect. SNAP-8's additional methionine and alanine residues at positions 3 and 7 increase hydrophobic interaction stability within the synaptobrevin binding pocket, prolonging the inhibitory effect at the neuromuscular junction. For topical formulations, this translates to sustained wrinkle reduction over 8–12 hours post-application, compared to 4–6 hours for Argireline at equivalent molar concentrations. Both peptides are non-toxic and reversible. The choice between them is efficacy duration, not mechanism.